Background: PMPS nowadays is common due to advances in both; diagnosis and treatment of cancer breast.
Introduction
Cancer breast is the most common cancer in women and second most common cancer overall. It is the fifth most common cause of death from cancer in women according to International Agency Of Research Variations observed in rates of incidence and mortality because to breast cancer, are due to a number of factors like age, race, socio-economic status, life style, reproductive history and finally family history [4] .
As a consequence of advancements in both diagnosis and treatments, the survival rate patients have increased. So, population susceptible to develop pain as a complication is expected to increase [5] . It When we mention different modalities of treatment, we must know that surgery is the keystone in the treatment of solid neoplastic tumors in general including breast cancer. Paradoxically, there is high risk of metastatic spread the perioperative period represents in cancer patients [11] . This is due to depression of antitumoral cellular immunity and depression occur in the postoperative period is linked to the metabolic and hormonal changes caused by the "stress reaction" to surgery [12] .
'By any reasonable code, freedom from pain should be a basic human right, limited only by our knowledge to achieve it' Ronald Melzack [13] . It is the basic duty of all healthcare professionals to relieve pain, and the most important indication for treating pain after surgery is humanitarian [13] . As pain is a nightmare for most patients and influences their overall experience [14] .
Usually adequate analgesia is achieved by following the WHO's step analgesic ladder. As the cancer progresses, the pain experienced by the patient increases. This necessitates the administration adjuvant analgesics with opioids to control this severe pain.
Unfortunately, analgesics affect immunity and tumor development by direct interfering with cellular mechanisms (e.g., cell apoptosis) or indirect interacting with the sympatho-adrenal systems [15] .
Persistent pain after mastectomy is common and about 20-50 percent women are complaining of persistent neuropathic pain after mastectomy [16] . More common among young patients, those undergoing radiotherapy and axillary lymph node dissection [17] .
There is a strong evidence that; suppression of the immune system in the perioperative period increase postoperative complications which includes bad wound healing infections leading to sepsis, multiple organ failure and death [18] . Also the development of residual malignant cells and the formation of new metastases are accelerated by immune suppression [19] .
Other concerns of the anesthesiologists are Pain features (neuropathic) are burning like sensation, paroxysmal lancinating pain, shock-like, and pinprick pain [25] .
The pain decrease everyday activities, social function and causes heavy economic burden for the healthcare system [26] . Several factors make PMPS persistent, like adjuvant therapy, psychosocial status, preoperative breast pain, type of surgery and type of analgesia. Being a problem of such important, should increase attention to PMPS [27] .
The pain is perceived mainly in the axilla, medial upper arm, breast, and chest wall after more than three months of surgery to eliminate all other causes of pain such as infection ( Figure 1 ) [28, 29] . [32] .
Consequences of Undermanaged PMPS
PMPS is a form of neuropathic pain caused by surgical trauma and is associated with an inflammatory reaction that has many consequences involving multiple organ systems, including local and systemic effects [33] . 
Sympatho-Adrenal and Metabolic Stress Responses

Chronic Pain
Untreated acute post mastectomy pain can be changed to chronic pain and this was proved by multiple studies. [36] Up regulation of peripheral nociception and increased nerve excitability due to prolonged exposure to noxious stimuli are the possible mechanisms. Noxious stimuli sensitize the nervous system response to subsequent stimuli. This is known as "windup" or "central sensitization" and is further illustrated in ( Figure 2 ) [37] .
Discussion
According to a previous review, the literature was inconsistent in defining chronic pain after • Phantom breast pain prevalence is (3-44) per cent;
• Intercostobrachial neuralgia (ICN) 16-39 percent for all breast cancer surgery;
• Neuroma pain prevalence is (23-49) percent.
[38]
There were many trials (randomized, doubled-blinded, placebo-controlled) done to investigate the best neuropathic pain treatment algorithm. Many trials were included studying a lot of neuropathic conditions. The most studied oral medications were; anti -depressants, anticonvulsants, opioids, NMDA antagonists, mexilitine, topical lidocaine, cannabinoids, topical capsaicin, and glycine antagonist.
We here mention the most effective methods for controlling PMPS that were published in last few years:
One prospective randomized controlled clinical study was done in South Egypt Cancer Institute, titled In moderate to severe pain or pain increasing in spite of step 2 treatment, stronger opioids are considered in addition. All these involve the concept However, current treatments of the PMPS are near-optimal and prevention much better than treatment. Further investigations are required to achieve the appropriate developments in diagnosis and screening of breast cancer, and evaluation and treatment of PMPS that will provide less side effects, adequate analgesia, and finally, improved quality of life, and patient satisfaction in the future.
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